Free Trial
ASX:NYR

Nyrada (NYR) Stock Price, News & Analysis

About Nyrada Stock (ASX:NYR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
65,000 shs
Average Volume
N/A
Market Capitalization
A$14.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NYR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyrada and its competitors with MarketBeat's FREE daily newsletter.

NYR Stock News Headlines

Noxopharm Reduces Stake in Nyrada Inc.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:NYR
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$1.39 million
Net Margins
-56.69%
Pretax Margin
N/A
Return on Equity
-28.93%
Return on Assets
-17.52%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.03
Quick Ratio
25.18

Sales & Book Value

Annual Sales
A$3.24 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
16.50
Book Value
A$0.03 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
182,210,000
Free Float
N/A
Market Cap
A$14.94 million
Optionable
Not Optionable
Beta
1.42
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:NYR) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners